Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial

Fig. 2

Cost-effectiveness acceptability curves of the different cost-effectiveness analyses, showing the probability that the intervention is cost-effective at different willingness to pay (WTP) thresholds. Abbreviations: bCBT, blended cognitive behaviour therapy; QALY, quality-adjusted life year; QLQ-C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us